Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
Journal of Applied Toxicology : JAT|June 6, 2021
Hydrogen sulfide alleviates apoptosis and autophagy induced by beryllium sulfate in 16HBE cellsYan-Ping Liu, Xiao-Yan Yuan, Xun-Ya Li, et al.
Neuroscience Bulletin|June 23, 2025
Enhanced Therapeutic Effects of Extracellular Vesicles Targeting MiR-137 Contribute to Functional Recovery by Attenuating Neuronal Injury After Ischemic StrokeHui-Xin Zhang, Li-Qing Tao, Yi-Hang Chen, et al.
Science Translational Medicine|July 12, 2023
PTEN deficiency facilitates gemcitabine efficacy in cancer by modulating the phosphorylation of PP2Ac and DCKTian-Yi Jiang, Xiao-Wen Cui, Tian-Mei Zeng, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|June 8, 2024
PTEN status determines therapeutic vulnerability to celastrol in cholangiocarcinomaYu-Fei Pan, Lin Zhong, Min Wang, et al.
Gastroenterology|November 27, 2022
PTEN Deficiency Facilitates Exosome Secretion and Metastasis in Cholangiocarcinoma by Impairing TFEB-mediated Lysosome BiogenesisTian-Yi Jiang, Yuan-Yuan Shi, Xiao-Wen Cui, et al.
Cancer Letters|February 17, 2018
Combination of Kras activation and PTEN deletion contributes to murine hepatopancreatic ductal malignancyYun-Kai Lin, Zheng Fang, Tian-Yi Jiang, et al.
Journal of Biomedical Science|February 27, 2025
Blocking the SIRPα-CD47 axis promotes macrophage phagocytosis of exosomes derived from visceral adipose tissue and improves inflammation and metabolism in miceYun-Kai Lin, Yu-Fei Pan, Tian-Yi Jiang, et al.
Oncotarget|January 22, 2015
RMP predicts survival and adjuvant TACE response in hepatocellular carcinomaJian Zhang, Tian-Yi Jiang, Bei-Ge Jiang, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|May 20, 2014
CKAP4 inhibited growth and metastasis of hepatocellular carcinoma through regulating EGFR signalingShuang-Xi Li, Li-Juan Liu, Li-Wei Dong, et al.
Cancer Letters|November 21, 2020
PTEN deficiency facilitates the therapeutic vulnerability to proteasome inhibitor bortezomib in gallbladder cancerTian-Yi Jiang, Xiao-Fan Feng, Zheng Fang, et al.
Pageof 3